Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xinshengning Tablets (心神宁片) is a traditional Chinese medicine (TCM) manufactured by Chengde JingFuKang Pharmaceutical Group. It is formulated based on the traditional therapeutic principle of "nourishing the blood and calming the mind" (Yangxue Anshen). The medication is primarily indicated for the treatment of insomnia, heart palpitations, dizziness, and amnesia, particularly those symptoms associated with heart and liver blood deficiency. The formulation typically consists of several herbal ingredients, including *Ziziphus jujuba* var. *spinosa* (Suanzaoren), *Polygala tenuifolia* (Yuanzhi), *Poria cocos* (Fuling), and *Gardenia jasminoides* (Zhizi). It is an approved and marketed product in China, categorized as a common medicine for neurological and calming purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xinshengning Tablets.